Please login or register to print this page.

Clinical Articles, Lead Article

Commentary on ENSURE-AF

British Junior Cardiologists Association (BJCA) President, Dr Jubin Joseph, who is also British Heart Foundation Clinical Research Fellow, at St Thomas’ Hospital, London, discussed ENSURE AF in our podcast (click here to view).

ENSURE-AF is a multinational phase 3 study, which evaluated the efficacy and safety of the oral, once-daily direct factor Xa-inhibitor edoxaban compared to enoxaparin/warfarin for the prevention of stroke, and other thrombotic complications, in patients with non-valvular atrial fibrillation (NVAF) undergoing electrical cardioversion. Dr Joseph discusses the implications for practice.

Published on: October 19, 2016

Members Area

Log in or Register now.

 For healthcare professionals only
Anticoagulation sky

SEARCH THE SITE

RSS FEED

Subscribe to our RSS feed
home

GET EXCLUSIVE UPDATES

Sign up for our regular email newsletters & be the first to know about fresh articles and site updates.

RECENT COMMENTS

    None Found

ENDORSED BY

  • ArrhythmiaAlliance
  • Stars
  • Anticoagulation Europe
  • Atrial Fibrillation Association
 

You are not logged in

You need to be a member to print this page.
Sign up for free membership, or log in.

You are not logged in

You need to be a member to download PDF's.
Sign up for free membership, or log in.